Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

IRWD POWR Grades

• IRWD scores best on the Quality dimension, with a Quality rank ahead of 99.56% of US stocks.
• IRWD's strongest trending metric is Momentum; it's been moving up over the last 178 days.
• IRWD's current lowest rank is in the Sentiment metric (where it is better than 24.08% of US stocks).

IRWD Stock Summary

• With a one year PEG ratio of 225.11, IRONWOOD PHARMACEUTICALS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 89.21% of US stocks.
• The volatility of IRONWOOD PHARMACEUTICALS INC's share price is greater than that of merely 7.46% US stocks with at least 200 days of trading history.
• IRONWOOD PHARMACEUTICALS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 14.58%, greater than the shareholder yield of 88.75% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to IRONWOOD PHARMACEUTICALS INC, a group of peers worth examining would be VRCA, GPRO, SONO, DVAX, and SGH.
• Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

• IRWD's price/sales ratio is 4.3; this is 115% higher than that of the median Healthcare stock.
• IRWD's price/sales ratio has moved down 27.9 over the prior 156 months.

Below are key valuation metrics over time for IRWD.

IRWD Growth Metrics

The year over year net cashflow from operations growth rate now stands at 26.84%.
• Its 4 year net cashflow from operations growth rate is now at 480.27%.
• Its 5 year cash and equivalents growth rate is now at 273.32%.

Over the past 70 months, IRWD's revenue has gone up $146,570,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	420.527	259.149	167.572
2022-06-30	415.637	265.122	173.1
2022-03-31	422.437	252.325	527.323
2021-12-31	413.753	261.895	528.448
2021-09-30	413.303	248.84	530.278
2021-06-30	413.024	227.407	508.856

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
• IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
• LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.